Aortic and ventricular dilation and myocardial reduction in gestation day 17 ICR mouse fetuses of diabetic mothers

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 79, Issue 6, 2007, Pages 459-464

  Gutierrez, J Claudio ^a   Hrubec, Terry C ^a,b   Prater, M Renee ^a,b   Smith, Bonnie J ^a   Freeman, Larry E ^a   Holladay, Steven D ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Cardiovascular malformations; Maternal diabetes mellitus; Type I diabetes

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANOMALY; ARTICLE; COMPUTER PROGRAM; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EXENCEPHALY; FEMALE; FETUS; FETUS HEART; GESTATIONAL AGE; HEART DEVELOPMENT; HEART DILATATION; HEART VENTRICLE; HEART VENTRICLE SIZE; HYPERGLYCEMIA; MALE; MATERNAL DIABETES MELLITUS; MATERNAL HYPERGLYCEMIA; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SPINA BIFIDA; TERATOGENESIS;

ANIMALS; AORTA, THORACIC; CARDIOMYOPATHY, HYPERTROPHIC; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DILATATION, PATHOLOGIC; FEMALE; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HEART RATE, FETAL; HEART VENTRICLES; HYPERGLYCEMIA; MALE; MICE; MICE, INBRED ICR; PREGNANCY; PREGNANCY IN DIABETICS;

MUS;

EID: 34250327533     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20357     Document Type: Article

References (26)

1. Abu-Sulaiman RM, Subaih B. 2004. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol 25:137-140.
2. Adeghate E. 2004. Molecular and cellular basis of the etiology and management of diabetic cardiomyopathy: a short review. Mol Cell Biochem 261:187-191.
3. Becerra JE, Khoury MJ, Cordero JF, et al. 1990. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 85:1-9.
4. Cai L, Li W, Wang G, et al. 2002. Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51:1938-1948.
5. Cederberg J, Picard JJ, Eriksson UJ. 2003. Maternal diabetes in the rat impairs the formation of neural-crest derived cranial nerve ganglia in the offspring. Diabetologia 46:1245-1251.
6. Clouthier DE, Hosoda K, Richardson JA, et al. 1998. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125:813-824.
7. Eriksson UJ, Borg LA, Forsberg H, et al. 1991. Diabetic embryopathy. Studies with animal and in vitro models. Diabetes 40 Suppl 2:94-98.
8. Frustaci A, Kajstura J, Chimenti C, et al. 2000. Myocardial cell death in human diabetes. Circ Res 87:1123-1132.
9. Henderson DJ, Conway SJ, Greene ND, et al. 2001. Cardiovascular defects associated with abnormalities in midline development in the Loop-tail mouse mutant. Circ Res 89:6-12.
10. Hrubec TC, Prater MR, Toops KA, et al. 2006. Reduction in diabetes-induced craniofacial defects by maternal immune stimulation. Birth Defects Res B Dev Reprod Toxicol 77:1-9.
11. Jaeggi ET, Fouron JC, Proulx F. 2001. Fetal cardiac performance in uncomplicated and well-controlled maternal type I diabetes. Ultrasound Obstet Gynecol 17:311-315.
12. Kaufman MH. 2003. The atlas of mouse development. Revised edition. San Diego: Academic Press.
13. Loffredo CA, Wilson PD, Ferencz C. 2001. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology 64:98-106.
14. Macklon NS, Hop WC, Wladimiroff JW. 1998. Fetal cardiac function and septal thickness in diabetic pregnancy: a controlled observational and reproducibility study. Br J Obstet Gynaecol 105:661-666.
15. Menezes HS, Barra M, Bello AR, et al. 2001. Fetal myocardial hypertrophy in an experimental model of gestational diabetes. Cardiol Young 11:609-613.
16. Meyer-Wittkopf M, Simpson JM, Sharland GK. 1996. Incidence of congenital heart defects in fetuses of diabetic mothers: a retrospective study of 326 cases. Ultrasound Obstet Gynecol 8:8-10.
17. Poelmann RE, Gittenberger-de Groot AC. 2005. Apoptosis as an instrument in cardiovascular development. Birth Defects Res C Embryo Today 75:305-313.
18. Punareewattana K, Holladay SD. 2004. Immunostimulation by complete Freund's adjuvant, granulocyte macrophage colony-stimulating factor, or interferon-gamma reduces severity of diabetic embryopathy in ICR mice. Birth Defects Res A Clin Mol Teratol 70:20-27.
19. Punareewattana K, Sharova LV, Li W, et al. 2003. Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice. Int Immunopharmacol 3:1639-1655.
20. Reece EA, Eriksson UJ. 1996. The pathogenesis of diabetes-associated congenital malformations. Obstet Gynecol Clin North Am 23:29-45.
21. Reece EA, Leguizamon G, Homko C. 1998. Pregnancy performance and outcomes associated with diabetic nephropathy. Am J Perinatol 15:413-421.
22. Roy S, Sala R, Cagliero E, et al. 1990. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 87:404-408.
23. Siman CM, Gittenberger-De Groot AC, Wisse B, et al. 2000. Malformations in offspring of diabetic rats: morphometric analysis of neural crest-derived organs and effects of maternal vitamin E treatment. Teratology 61:355-367.
24. Smoak IW. 2004. Hyperglycemia-induced TGFbeta and fibronectin expression in embryonic mouse heart. Dev Dyn 231:179-189.
25. Weber HS, Botti JJ, Baylen BG. 1994. Sequential longitudinal evaluation of cardiac growth and ventricular diastolic filling in fetuses of well controlled diabetic mothers. Pediatr Cardiol 15:184-189.
26. Wong SF, Chan FY, Cincotta RB, et al. 2003. Cardiac function in fetuses of poorly-controlled pre-gestational diabetic pregnancies - a pilot study. Gynecol Obstet Invest 56:113-116.